Published in MMW Fortschr Med on March 04, 2010
Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study. Neurobiol Aging (2007) 1.10
Association of serotonin transporter promoter gene polymorphism with violence: relation with personality disorders, impulsivity, and childhood ADHD psychopathology. Behav Sci Law (2004) 1.07
Detection of changed regional cerebral blood flow in mild cognitive impairment and early Alzheimer's dementia by perfusion-weighted magnetic resonance imaging. Neuroimage (2007) 1.04
The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia. Psychiatry Res (2010) 0.93
Intake of copper has no effect on cognition in patients with mild Alzheimer's disease: a pilot phase 2 clinical trial. J Neural Transm (Vienna) (2008) 0.89
Cognitive decline correlates with low plasma concentrations of copper in patients with mild to moderate Alzheimer's disease. J Alzheimers Dis (2005) 0.87
Quantitative EEG in progressing vs stable mild cognitive impairment (MCI): results of a 1-year follow-up study. Int J Geriatr Psychiatry (2008) 0.85
Epidemiology, symptoms, and treatment characteristics of hyponatremic psychiatric inpatients. J Clin Psychopharmacol (2013) 0.83
Blood biomarkers of osteoporosis in mild cognitive impairment and Alzheimer's disease. J Neural Transm (Vienna) (2009) 0.82
Multielectrode array analysis of cerebrospinal fluid in Alzheimer's disease versus mild cognitive impairment: a potential diagnostic and treatment biomarker. Biochem Biophys Res Commun (2013) 0.79
Anosognosia and depression in patients with Alzheimer's dementia. Arch Gerontol Geriatr (2013) 0.78
[Integrating patients with dementia and anosognosia into community care by a psychogeriatric consultation service]. Psychiatr Prax (2011) 0.77
Repressive Coping Does Not Contribute to Anosognosia in First-Diagnosis Patients With Alzheimer Disease. Alzheimer Dis Assoc Disord (2016) 0.75
[Assessment-Based Home Treatment for People with Severe Psychotic Disorders]. Psychiatr Prax (2015) 0.75
Resumption of food and fluid intake in Alzheimer's disease with severe apathy following intravenous citalopram. Psychiatry Clin Neurosci (2012) 0.75